<?xml version="1.0" encoding="UTF-8"?>
<document id="29519717">
	<sentence id="s1" text="Mutations in positive regulation of transcription by RNA polymerase II and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
		<entity id="s1.e1" charOffset="13-70"
			type="GO" text="positive regulation of transcription by RNA polymerase II" ontology_id="GO_0045944"/>
		<entity id="s1.e2" charOffset="75-100"
			type="GO" text="oxidative phosphorylation" ontology_id="GO_0006119"/>
		<entity id="s1.e3" charOffset="129-155"
			type="HP" text="neurodegenerative diseases" ontology_id="HP_0002180"/>
		<entity id="s1.e4" charOffset="222-245"
			type="HP" text="frontotemporal dementia" ontology_id="HP_0002145"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p4" e1="s1.e2"
		    e2="s1.e6" pgr="true"/>
	</sentence>
	<sentence id="s2" text="None of the patients showed positive regulation of transcription by RNA polymerase II mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in oxidative phosphorylation.">
		<entity id="s2.e1" charOffset="28-85"
			type="GO" text="positive regulation of transcription by RNA polymerase II" ontology_id="GO_0045944"/>
		<entity id="s2.e2" charOffset="107-115"
			type="HP" text="sporadic" ontology_id="HP_0003745"/>
		<entity id="s2.e3" charOffset="173-198"
			type="GO" text="oxidative phosphorylation" ontology_id="GO_0006119"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
</document>
